Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms
Abstract Intestinal epithelial cell damage caused by SARS-CoV-2 infection was thought to be associated with gastrointestinal symptoms and decreased fecal consistency. The association of the gastrointestinal symptoms with the COVID-19-mediated inflammatory response triggered by the gastrointestinal i...
Saved in:
Main Authors: | Hajar Shokri-Afra, Ahmad Alikhani, Bahman Moradipoodeh, Farshid Noorbakhsh, Hafez Fakheri, Hemen Moradi-Sardareh |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e3830e34d4924d4a8b30f4751c3ab77d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fecal calprotectin and microbiota of the gut
by: V. G. Gorokhova, et al.
Published: (2016) -
Fecal calprotectin in healthy children aged 4–16 years
by: María Roca, et al.
Published: (2020) -
Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
by: Cao Y, et al.
Published: (2021) -
Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
by: Ning Li, et al.
Published: (2021) -
Corrigendum: Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study
by: Ning Li, et al.
Published: (2021)